vs
Side-by-side financial comparison of Citius Pharmaceuticals, Inc. (CTXR) and HeartCore Enterprises, Inc. (HTCR). Click either name above to swap in a different company.
Citius Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($3.9M vs $3.0M, roughly 1.3× HeartCore Enterprises, Inc.). HeartCore Enterprises, Inc. runs the higher net margin — 14.5% vs -238.2%, a 252.7% gap on every dollar of revenue.
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing innovative prescription therapies addressing unmet medical needs across critical care, oncology, anti-infective treatment, and supportive care segments, primarily serving the U.S. healthcare market.
HeartCore Enterprises, Inc. is a global SaaS provider specializing in customer experience management, digital transformation solutions, and marketing technology tools. It operates mainly in Japan, Asia-Pacific, and North America, serving small-to-medium businesses and large enterprises with content management systems, marketing automation platforms, and CRM solutions.
CTXR vs HTCR — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $3.0M |
| Net Profit | $-9.4M | $434.1K |
| Gross Margin | 80.0% | 49.1% |
| Operating Margin | -228.7% | -0.4% |
| Net Margin | -238.2% | 14.5% |
| Revenue YoY | — | -81.6% |
| Net Profit YoY | 8.6% | -96.1% |
| EPS (diluted) | $-0.38 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | — | ||
| Q3 25 | — | $3.0M | ||
| Q2 25 | — | $4.7M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | — | $16.2M | ||
| Q2 24 | — | $4.1M | ||
| Q1 24 | — | $5.0M |
| Q4 25 | $-9.4M | — | ||
| Q3 25 | — | $434.1K | ||
| Q2 25 | — | $1.1M | ||
| Q1 25 | — | $-3.1M | ||
| Q4 24 | — | $-9.3M | ||
| Q3 24 | — | $11.1M | ||
| Q2 24 | — | $-2.0M | ||
| Q1 24 | — | $-1.3M |
| Q4 25 | 80.0% | — | ||
| Q3 25 | — | 49.1% | ||
| Q2 25 | — | 46.7% | ||
| Q1 25 | — | 30.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 19.8% | ||
| Q1 24 | — | 40.3% |
| Q4 25 | -228.7% | — | ||
| Q3 25 | — | -0.4% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | -34.7% | ||
| Q4 24 | — | 386.5% | ||
| Q3 24 | — | 76.0% | ||
| Q2 24 | — | -37.1% | ||
| Q1 24 | — | -13.5% |
| Q4 25 | -238.2% | — | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 23.2% | ||
| Q1 25 | — | -86.1% | ||
| Q4 24 | — | 346.8% | ||
| Q3 24 | — | 68.1% | ||
| Q2 24 | — | -48.0% | ||
| Q1 24 | — | -26.4% |
| Q4 25 | $-0.38 | — | ||
| Q3 25 | — | $0.02 | ||
| Q2 25 | — | $0.04 | ||
| Q1 25 | — | $-0.14 | ||
| Q4 24 | — | $-0.45 | ||
| Q3 24 | — | $0.53 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.7M | $4.4M |
| Total DebtLower is stronger | — | $510.9K |
| Stockholders' EquityBook value | $80.0M | $5.2M |
| Total Assets | $140.4M | $13.3M |
| Debt / EquityLower = less leverage | — | 0.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.7M | — | ||
| Q3 25 | — | $4.4M | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | — | $8.6M | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $1.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | $510.9K | ||
| Q2 25 | — | $1.5M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | — | $545.1K | ||
| Q3 24 | — | $1.9M | ||
| Q2 24 | — | $1.9M | ||
| Q1 24 | — | $2.0M |
| Q4 25 | $80.0M | — | ||
| Q3 25 | — | $5.2M | ||
| Q2 25 | — | $4.8M | ||
| Q1 25 | — | $1.8M | ||
| Q4 24 | — | $4.7M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | — | $1.6M | ||
| Q1 24 | — | $3.9M |
| Q4 25 | $140.4M | — | ||
| Q3 25 | — | $13.3M | ||
| Q2 25 | — | $13.5M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | — | $14.0M | ||
| Q3 24 | — | $25.5M | ||
| Q2 24 | — | $24.1M | ||
| Q1 24 | — | $22.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 0.31× | ||
| Q1 25 | — | 0.84× | ||
| Q4 24 | — | 0.12× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 0.50× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-13.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-674.1K | ||
| Q1 25 | — | $-2.0M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | — | $-1.8M | ||
| Q2 24 | — | $-837.1K | ||
| Q1 24 | — | $-898.6K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.61× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.16× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTXR
Segment breakdown not available.
HTCR
| Customised Software Development And Services | $1.7M | 58% |
| Software Related Cost Of Revenues | $1.4M | 46% |
